-+ 0.00%
-+ 0.00%
-+ 0.00%

ITM: PLANS TO RESUBMIT NDA FOR 177LU-EDOTREOTIDE AFTER ADDRESSING FDA FEEDBACK

Reuters·08/10/2026 14:17:09

Please log in to view news